Literature DB >> 21320290

Immunophenotyping in peripheral blood mononuclear cells, aqueous humour and vitreous in a Blau syndrome patient caused by a novel NOD2 mutation.

M C Jimenez-Martinez1, F Cruz, S Groman-Lupa, J C Zenteno.   

Abstract

The genetic and immunophenotypic characteristics of a 3-year-old patient with Blau syndrome (BS), an early onset sarcoidosis caused by mutations in NOD2, were investigated. Molecular analysis of NOD2 gene was achieved by PCR and direct nucleotide sequencing. Immunophenotyping included cytometric analysis of memory-effector markers on T-cells, and cytokine in serum, aqueous humour and vitreous. A novel M513R mutation in NOD2 was demonstrated. Immunophenotyping revealed higher frequency of CCR4+ cells and CCR9+ cells on CD4+ cells; most CD8+ cells were CCR7- and CCR9+. IL6 and IL-8 were detected in a gradient manner: vitreous humour>aqueous humour>serum. The immunophenotype in this patient was characterized by a differential expression of chemokine receptors on T cells and by a particular ocular microenvironment enriched in IL-6 and IL-8. To our knowledge, this is the first study analysing the immunological features of BS at aqueous humour, vitreous and blood levels. Our results expand the knowledge of the genetic and immunopathological basis of BS.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320290     DOI: 10.1111/j.1744-313X.2011.00998.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  5 in total

Review 1.  NOD1 and NOD2 in inflammatory and infectious diseases.

Authors:  Bruno C Trindade; Grace Y Chen
Journal:  Immunol Rev       Date:  2020-07-17       Impact factor: 12.988

Review 2.  Early diagnosis of early-onset sarcoidosis: a case report with functional analysis and review of the literature.

Authors:  Yusuke Takeuchi; Tomonari Shigemura; Norimoto Kobayashi; Naoe Kaneko; Tomoyuki Iwasaki; Kisei Minami; Keiko Kobayashi; Junya Masumoto; Kazunaga Agematsu
Journal:  Clin Rheumatol       Date:  2017-01-27       Impact factor: 3.650

3.  Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients.

Authors:  Song Zhang; Zhe Cai; Xiaolan Mo; Huasong Zeng
Journal:  Pediatr Rheumatol Online J       Date:  2021-11-15       Impact factor: 3.054

Review 4.  Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease.

Authors:  Francesco Caso; Paola Galozzi; Luisa Costa; Paolo Sfriso; Luca Cantarini; Leonardo Punzi
Journal:  RMD Open       Date:  2015-07-20

5.  T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis.

Authors:  Ruth J Napier; Ellen J Lee; Michael P Davey; Emily E Vance; João M Furtado; Paige E Snow; Kimberly A Samson; Sydney J Lashley; Brieanna R Brown; Reiko Horai; Mary J Mattapallil; Biying Xu; Michelle C Callegan; Luke S Uebelhoer; Christina L Lancioni; Richard K Vehe; Bryce A Binstadt; Justine R Smith; Rachel R Caspi; Holly L Rosenzweig
Journal:  Nat Commun       Date:  2020-10-26       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.